Apimeds Pharmaceuticals US, Inc (APUS)
Apimeds Pharmaceuticals US, Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Matawan, NJ, US. The stock last traded at $7.25, up 47.36% on the session, giving a market capitalisation of $10.9M. On trailing twelve-month figures it carries a trailing P/E of -0.15, a net margin of 0.0%. Its beta of 0.15 implies it has historically moved less than the broad market.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Apimeds Pharmaceuticals US, Inc is most often compared with the following Healthcare names: